Details for Patent: RE29892
✉ Email this page to a colleague
Summary for Patent: RE29892
| Title: | Composition and method of treating dopamine deficiency in brain tissue |
| Abstract: | The dopamine content in brain tissue of animals is increased by administering to the animal L-dopa or its salts in combination with L-.alpha.-hydrazino-.alpha.-lower alkyl-3,4-dihydroxyphenyl propionic acid or its salts .[.or .alpha.-hydrazino-3,4-dihydroxyphenyl propionic acid or its salts.].. The increased dopamine content in brain tissue tends to alleviate some of the symptoms caused by Parkinsonism and similar diseases. |
| Inventor(s): | Bayne; Gilbert M. (Lansdale, PA) |
| Assignee: | Merck & Co. Inc. (Rahway, NJ) |
| Application Number: | 05/790,155 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; |
Drugs Protected by US Patent RE29892
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
